Day One Biopharmaceuticals
DAWN
NASDAQ
IPO2021
about DAWN
Day One Biopharmaceuticals specializes in developing innovative therapies using advanced technologies such as artificial intelligence and machine learning to address challenges in oncology and rare diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $21.12 | $21.23 | $21.08 | $1.3B | 78.37M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.19 | n/a | 55.15 | -60.94% | 0% | 0% |